This bill aims to enhance oversight and accountability of the 340B Drug Pricing Program in Minnesota by authorizing independent audits of 340B covered entities conducted by nonprofit public interest organizations. It introduces a new definition for "nonprofit public interest organization" and allows these organizations to audit 340B entities to ensure compliance with relevant laws. The bill mandates that 340B covered entities must cooperate with these audits by providing necessary data and information, while also ensuring that the confidentiality of the information is maintained.

Additionally, the bill requires that 340B covered entities allocate at least 25 percent of their net revenue from the 340B program towards charity care, explicitly excluding medical debt write-offs and community service from this calculation. The enforcement of this requirement is not only the responsibility of the commissioner but also includes the attorney general, thereby strengthening the enforcement mechanisms in place. Overall, the bill seeks to ensure that the benefits of the 340B program are directed towards charitable healthcare services in Minnesota.

Statutes affected:
Introduction: 62J.461